These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33088639)
1. Possible involvement of autoimmunity in fulminant type 1 diabetes. Oikawa Y; Shimada A Diabetol Int; 2020 Oct; 11(4):329-335. PubMed ID: 33088639 [TBL] [Abstract][Full Text] [Related]
2. Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition. Luo S; Ma X; Li X; Xie Z; Zhou Z Diabetes Metab Res Rev; 2020 Sep; 36(6):e3317. PubMed ID: 32223049 [TBL] [Abstract][Full Text] [Related]
3. Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic. Sano H; Imagawa A Biology (Basel); 2022 Nov; 11(11):. PubMed ID: 36421377 [TBL] [Abstract][Full Text] [Related]
4. A mimic of viral double-stranded RNA triggers fulminant type 1 diabetes-like syndrome in regulatory T cell-deficient autoimmune diabetic mouse. Tada A; Shimada A; Yamada T; Oikawa Y; Yamada Y; Okubo Y; Irie J; Bluestone JA; Itoh H J Immunol; 2011 Nov; 187(10):4947-53. PubMed ID: 21967896 [TBL] [Abstract][Full Text] [Related]
5. A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype. Takeno A; Kanazawa I; Morita M; Takedani K; Miyake H; Yamamoto M; Nogami K; Kaneko S; Sugimoto T Endocr J; 2018 Jan; 65(1):129-132. PubMed ID: 28966225 [TBL] [Abstract][Full Text] [Related]
6. Recent findings on fulminant type 1 diabetes. Liu L; Zeng L; Sang D; Lu Z; Shen J Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28817230 [TBL] [Abstract][Full Text] [Related]
7. Fulminant type 1 diabetes developed after influenza split vaccination. Sawamura T; Karashima S; Ohmori A; Sawada K; Aono D; Kometani M; Takeda Y; Yoneda T Endocrinol Diabetes Metab Case Rep; 2023 May; 2023(2):. PubMed ID: 37140990 [TBL] [Abstract][Full Text] [Related]
8. Fulminant type 1 diabetes patients display high frequencies of IGRP-specific type 1 CD8 Chujo D; Kawabe A; Matsushita M; Tsutsumi C; Haseda F; Imagawa A; Hanafusa T; Ueki K; Kajio H; Yagi K; Tobe K; Shimoda M Clin Immunol; 2021 Dec; 233():108893. PubMed ID: 34808330 [TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral. Kusuki K; Suzuki S; Mizuno Y Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. Wang Z; Zheng Y; Hou C; Yang L; Li X; Lin J; Huang G; Lu Q; Wang CY; Zhou Z J Autoimmun; 2013 Mar; 41():50-9. PubMed ID: 23490285 [TBL] [Abstract][Full Text] [Related]
11. Fulminant type 1 diabetes: 20 years of discovery and development. Hanafusa T Diabetol Int; 2020 Oct; 11(4):310-314. PubMed ID: 33088636 [TBL] [Abstract][Full Text] [Related]
12. The fulminant index: A method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis. Qiu J; Li X; Chen W; Ma X; Xie Z; Huang G; Luo S; Zhou Z Diabetes Metab Res Rev; 2022 Mar; 38(3):e3501. PubMed ID: 34614535 [TBL] [Abstract][Full Text] [Related]
13. Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection. Murakawa K; Aasi H; Sato K; Yoshioka S; Sho H; Inui R; Kosugi M; Hazama Y; Yasuda T Diabetol Int; 2024 Jul; 15(3):621-626. PubMed ID: 39101178 [TBL] [Abstract][Full Text] [Related]
14. Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3 Subtypes of Type 1 Diabetes. Chujo D; Kawabe A; Matsushita M; Takahashi N; Tsutsumi C; Haseda F; Imagawa A; Hanafusa T; Ueki K; Kajio H; Yagi K; Tobe K; Shimoda M J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32652026 [TBL] [Abstract][Full Text] [Related]
15. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Kobayashi T; Nishida Y; Tanaka S; Aida K Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294 [TBL] [Abstract][Full Text] [Related]
16. Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes. Haseda F; Imagawa A; Nishikawa H; Mitsui S; Tsutsumi C; Fujisawa R; Sano H; Murase-Mishiba Y; Terasaki J; Sakaguchi S; Hanafusa T PLoS One; 2016; 11(8):e0160576. PubMed ID: 27513516 [TBL] [Abstract][Full Text] [Related]
17. Fulminant type 1 diabetes: Focusing on triggering factors. Qiu J; Yin W; Wang R; Luo S; Zhou Z Diabetes Metab Res Rev; 2024 Feb; 40(2):e3731. PubMed ID: 37814918 [TBL] [Abstract][Full Text] [Related]
18. Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes. Saheki T; Imachi H; Ibata T; Fukunaga K; Yoshioka Y; Kobayashi T; Sato S; Mizumoto K; Yoshimoto T; Lyu J; Dong T; Murao K Intern Med; 2019 Jul; 58(13):1913-1916. PubMed ID: 30918186 [TBL] [Abstract][Full Text] [Related]
19. Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore. Tan SYT; Rama Chandran S; Yew J; Wong AJ; Gardner DS J Diabetes Investig; 2024 Jun; 15(6):786-789. PubMed ID: 38444298 [TBL] [Abstract][Full Text] [Related]
20. Fulminant type 1 diabetes caused by DIHS could be affected by the reactivation of HHV-6. Makino H; Tohyama M; Kawamura R; Takata Y; Osawa H; Onuma H J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38298135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]